Overall rank by patents
#41,567
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 2 technology areas, active 2016–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
The verdict
Merlin holds 6 US patents across 2 technology areas, rank #41,567 of 50,000 tracked assignees.
Merlin MD PTE Ltd. has been granted 6 US utility patents between 2016 and 2021, placing Merlin MD PTE Ltd. at rank #41,567 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 28.2 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, Merlin MD PTE Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Merlin sits between Mentice AB (6 patents, rank #41,563) and Metamaterial Technologies USA, Inc. (6 patents, rank #41,571) - the closest US assignees by grant volume. The composite Innovation Score of 26.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 4 in the 2015–2019 window, a -50% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Merlin MD PTE Ltd.'s 28.2 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Merlin MD PTE Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MENTICE AB
6 patents
MEOPTA—OPTIKA, S.R.O.
6 patents
MEPROLIGHT (1990) LTD.
6 patents
MERCIA PHARMA, INC.
6 patents
MESA PHOTONICS, LLC
6 patents
MESDAN S.P.A.
6 patents
MESTER LED LIMITED
6 patents
METAMATERIAL TECHNOLOGIES USA, INC.
6 patents
MERLIN MD PTE LTD.
6 patents
What this shows Merlin holds 6 patents at rank #41,567, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #41,567 in granted patent volume.
Other assignees with the most granted patents in Merlin's primary technology class.
Merlin's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
27 Top 79% higher than 21% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 16.7% |
| 2017 | 2 | 33.3% |
| 2019 | 1 | 16.7% |
| 2021 | 2 | 33.3% |
Top 2 of 2 technology areas
Overall rank by patents
#41,567
Across all tracked assignees
26.7 out of 100
How to use this portfolio
Merlin's 6 grants land it in the top 79% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.